Efficacy of Haloperidol and Ondansetron in the Treatment of Hiccups
Chlorpromazine is the only FDA-approved medication for hiccups, but haloperidol has demonstrated efficacy for intractable hiccups while ondansetron has not shown significant evidence for hiccup treatment. 1
Haloperidol for Hiccups
- Haloperidol, a butyrophenone antipsychotic, has demonstrated efficacy in treating persistent and intractable hiccups based on clinical evidence 2
- The mechanism likely involves central action on dopamine receptors in the hiccup reflex arc 3
- Typical dosing for hiccup treatment ranges from 1-2 mg orally every 4-6 hours as needed 1
- Haloperidol can be considered as an alternative to chlorpromazine, which is the only FDA-approved medication specifically for hiccups 4
Side Effects and Monitoring with Haloperidol
- Common side effects include extrapyramidal symptoms (dystonic reactions), orthostatic hypotension, sinus tachycardia, and other dysrhythmias 1
- QTc prolongation is a significant concern, requiring ECG monitoring in at-risk patients 1
- When using haloperidol for hiccups, close clinical observation is recommended, especially in patients with cardiac risk factors 1
- Diphenhydramine (25-50 mg PO or IV every 4-6 hours) may be needed to manage dystonic reactions 1
Ondansetron for Hiccups
- There is no substantial evidence supporting ondansetron's efficacy in treating hiccups 2, 5
- Ondansetron is primarily indicated for chemotherapy-induced and radiation-induced nausea and vomiting 1
- Standard dosing for ondansetron is 8 mg orally or IV for antiemetic purposes, but this has not been established for hiccup treatment 1
- Ondansetron is also listed as a QT-interval prolonging medication, which should be considered when evaluating treatment options 1
Treatment Algorithm for Hiccups
First-line options:
Second-line options:
For intraoperative hiccups:
- Chlorpromazine has been shown to be effective even under general anesthesia (5 mg IV total dose) 6
Important Considerations
- Treatment should target the underlying cause of hiccups when identifiable 5
- For intractable hiccups, a trial of anti-reflux therapy may be appropriate before moving to neuroleptic agents 5
- Baclofen and gabapentin may have better safety profiles than neuroleptic agents like haloperidol for long-term therapy 5
- When using haloperidol, monitor for QTc prolongation, especially if combined with other QT-prolonging medications 1
- Chlorpromazine remains the standard FDA-approved treatment, but its side effect profile may be less favorable than newer agents 4